Literature DB >> 24180445

Reply: Objective measurement of the therapeutic effectiveness of continuous positive airway pressure versus oral appliance therapy for the treatment of obstructive sleep apnea.

David P White1.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24180445      PMCID: PMC3863743          DOI: 10.1164/rccm.201305-0940LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Continuous positive airway pressure versus the mandibular advancing splint: are they equally effective in obstructive sleep apnea management?

Authors:  David P White
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

2.  Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial.

Authors:  Craig L Phillips; Ronald R Grunstein; M Ali Darendeliler; Anastasia S Mihailidou; Vasantha K Srinivasan; Brendon J Yee; Guy B Marks; Peter A Cistulli
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

3.  Sleep endoscopy with simulation bite for prediction of oral appliance treatment outcome.

Authors:  Anneclaire V M T Vroegop; Olivier M Vanderveken; Marijke Dieltjens; Kristien Wouters; Vera Saldien; Marc J Braem; Paul H Van de Heyning
Journal:  J Sleep Res       Date:  2012-12-04       Impact factor: 3.981

4.  Remotely controlled mandibular protrusion during sleep predicts therapeutic success with oral appliances in patients with obstructive sleep apnea.

Authors:  John Remmers; Shouresh Charkhandeh; Joshua Grosse; Zbigniew Topor; Rollin Brant; Peter Santosham; Sabina Bruehlmann
Journal:  Sleep       Date:  2013-10-01       Impact factor: 5.849

5.  Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing.

Authors:  Olivier M Vanderveken; Marijke Dieltjens; Kristien Wouters; Wilfried A De Backer; Paul H Van de Heyning; Marc J Braem
Journal:  Thorax       Date:  2012-09-19       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.